Jump to Content Jump to Main Navigation
Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo
Society for Endocrinology logo
Sign in Create account
Home Browse
Impact Factor Collection Highlights of 2021 Editor's choice Accepted manuscripts Current issue All issues Special issues Themed Collections
Submit now Author guidelines Reasons to publish Ethical policy Post-publication changes Open-access policy Publication charges Author resource centre
Contact the journal Scope Editorial board Societies For libraries Subscribe Abstracting and indexing
Alerts Journals
Advanced Search Help
Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo
Society for Endocrinology logo
Sign in Create account
Home Browse
Impact Factor Collection Highlights of 2021 Editor's choice Accepted manuscripts Current issue All issues Special issues Themed Collections
Submit now Author guidelines Reasons to publish Ethical policy Post-publication changes Open-access policy Publication charges Author resource centre
Contact the journal Scope Editorial board Societies For libraries Subscribe Abstracting and indexing
Alerts Journals
Advanced Search Help

Volume 27 (2020): Issue 2 (Feb 2020)

in Endocrine-Related Cancer
Online ISSN:
1479-6821
Print ISSN:
1351-0088

Articles are added to the current issue and list of accepted manuscripts on an ongoing basis, reflecting the journal's continuous publication.

Sign up using the buttons to receive email notifications of the latest research.

  • Sign up for new article alerts
  • Sign up for eTOC alerts
  • Get Accepted Manuscript Alerts
  • Review
    • The epigenetic and transcriptional landscape of neuroendocrine prostate cancer
    • A lex naturalis delineates components of a human-specific, adrenal androgen-dependent, p53-mediated ‘kill switch’ tumor suppression mechanism
  • Research
    • Photodynamic therapy enables tumor-specific ablation in preclinical models of thyroid cancer
    • The ERβ5 splice variant increases oestrogen responsiveness of ERαpos Ishikawa cells
    • Androgen modulation of XBP1 is functionally driving part of the AR transcriptional program
    • LDLR-mediated lipidome–transcriptome reprogramming in cisplatin insensitivity
    • Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response
    • Novel three-dimensional cultures provide insights into thyroid cancer behavior
  • Erratum
    • SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer
    • Hyperglycemia decreases anti-cancer efficiency of adriamycin via AMPK pathway
  • Save
  • Collapse
  • Expand
  • Top
Print ISSN:
1351-0088
Online ISSN:
1479-6821

Online ISSN: 1479-6821
Print ISSN: 1351-0088

Follow the journal on Twitter

Author Information

Author Guidelines

Open Access Policy

Permissions

Librarian Information

General Information

Subscribe

Read and Publish Deal

General Information

Contact the journal

Advertising

Help

Bioscientifica logo

Strengthening biomedical communities
to advance science and health

 

Accessibility

Privacy and Cookies

Terms and Conditions

 

About Bioscientifica

All Bioscientifica Journals

Publishing Alliances

 

CONTACT US

Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK

Bioscientifica Ltd | Registered in England no 3190519

© 2023 Bioscientifica Ltd
Powered by PubFactory
  • [3.231.217.107]
  • 3.231.217.107
Close
Edit

Character limit 500/500

@!

Character limit 500/500